tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

IUGNF Stock Latest News

Imugene’s Azer-cel Receives FDA Fast Track Designation for DLBCL
Company AnnouncementsImugene’s Azer-cel Receives FDA Fast Track Designation for DLBCL
14d ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany Announcements
Imugene Limited Announces Quotation of New Securities on ASX
20d ago
Imugene Limited Reports Progress in Cancer Therapies
PremiumCompany Announcements
Imugene Limited Reports Progress in Cancer Therapies
23d ago
Imugene Appoints Darren Keamy as CFO and Company Secretary
PremiumCompany Announcements
Imugene Appoints Darren Keamy as CFO and Company Secretary
29d ago
Imugene Secures Indian Patent for CF33 Oncolytic Virotherapy
PremiumCompany Announcements
Imugene Secures Indian Patent for CF33 Oncolytic Virotherapy
1M ago
Imugene Secures Patent for OnCARlytics in China, Strengthening Market Position
PremiumCompany AnnouncementsImugene Secures Patent for OnCARlytics in China, Strengthening Market Position
1M ago
Imugene Limited Announces Change in Director’s Interest
Premium
Company Announcements
Imugene Limited Announces Change in Director’s Interest
1M ago
Imugene Limited Issues Unquoted Equity Securities to Boost Growth
Premium
Company Announcements
Imugene Limited Issues Unquoted Equity Securities to Boost Growth
1M ago
Imugene Expands Capital with New Securities Quotation
PremiumCompany Announcements
Imugene Expands Capital with New Securities Quotation
1M ago
Imugene’s Azer-cel Shows Promising Results in CAR-T Phase 1b Trial
PremiumCompany Announcements
Imugene’s Azer-cel Shows Promising Results in CAR-T Phase 1b Trial
2M ago
Imugene Reports Key Milestones in Cancer Trials and Financial Strengthening
PremiumCompany Announcements
Imugene Reports Key Milestones in Cancer Trials and Financial Strengthening
2M ago
Imugene Limited Adjusts Securities Portfolio with Cessation of Restricted Stock Units
PremiumCompany Announcements
Imugene Limited Adjusts Securities Portfolio with Cessation of Restricted Stock Units
2M ago
Imugene Limited Announces Quotation of New Securities on ASX
PremiumCompany AnnouncementsImugene Limited Announces Quotation of New Securities on ASX
2M ago
Imugene Secures A$20 Million to Advance Clinical Trials
Premium
Company Announcements
Imugene Secures A$20 Million to Advance Clinical Trials
2M ago
Imugene Limited Issues Convertible Notes and Warrants to Fund Cancer Immunotherapy Efforts
Premium
Company Announcements
Imugene Limited Issues Convertible Notes and Warrants to Fund Cancer Immunotherapy Efforts
2M ago
Imugene Releases Shares from Voluntary Escrow
PremiumCompany Announcements
Imugene Releases Shares from Voluntary Escrow
2M ago
Imugene Secures $46 Million Investment to Boost Clinical Trials
PremiumCompany Announcements
Imugene Secures $46 Million Investment to Boost Clinical Trials
2M ago
Imugene Limited Issues Unquoted Equity Securities for Employee Incentive
PremiumCompany Announcements
Imugene Limited Issues Unquoted Equity Securities for Employee Incentive
2M ago
Imugene Limited Successfully Passes All Resolutions at Extraordinary General Meeting
PremiumCompany Announcements
Imugene Limited Successfully Passes All Resolutions at Extraordinary General Meeting
2M ago
Imugene Limited Announces Progress Amidst Strong Financial Standing
PremiumCompany AnnouncementsImugene Limited Announces Progress Amidst Strong Financial Standing
2M ago
Imugene Limited Announces New Securities Quotation on ASX
Premium
Company Announcements
Imugene Limited Announces New Securities Quotation on ASX
3M ago
Imugene Secures $11.7m R&D Tax Refund to Boost Cancer Therapy Development
Premium
Company Announcements
Imugene Secures $11.7m R&D Tax Refund to Boost Cancer Therapy Development
3M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >